newsfilter
← Latest News
Business Wire·

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH.This press release features multimedia. View the full release here: